Publications by authors named "S P Johnstone"

Objective: Since the federal Canadian government legalized cannabis in 2018, cannabis use in the general population has slightly increased. However, little is known about the impact of cannabis legalization on pattens of cannabis use in psychiatric populations.

Method: We studied changes in daily/almost daily and average 30-day cannabis use amongst individuals currently using cannabis who reported past 12-month experiences of specific mental health disorders and among those without past 12-month experiences of any mental health disorder before and after Canadian legalization of recreational cannabis use ( = 13,527).

View Article and Find Full Text PDF

The recent global COVID-19 pandemic has highlighted treatments for coronavirus infection as an unmet medical need. The main protease (M) has been an important target for the development of SARS-CoV-2 direct-acting antivirals. Nirmatrelvir as a covalent M inhibitor was the first such approved therapy.

View Article and Find Full Text PDF

Background: Smoking rates in schizophrenia are exceptionally high; however, cessation rates remain low with limited research on effective interventions. A critical component of intervention development is identifying the effects of abstinence that are most salient and therefore may contribute to lapse and relapse.

Objectives: We conducted a systematic review and meta-analysis of controlled laboratory studies investigating acute smoking abstinence effects among people with schizophrenia and schizoaffective disorder.

View Article and Find Full Text PDF

Background: Previous research has characterised EEG changes associated with resting activation in primary school children and adults, while task-related activation has only been considered in adults. The current study characterises physiological activation in preschool children and examines the potential value of activation indices for predicting mental health status at two time points.

Aims: To investigate how resting activation and task-related activation are represented in 4- to 5-year-old preschool children and examine if these activation indices can predict current and future mental health status.

View Article and Find Full Text PDF
Article Synopsis
  • Systolic heart failure is characterized by reduced muscle contractility and mitochondrial function, but there is currently no treatment that addresses both issues.
  • Researchers used adeno-associated virus (AAV) to deliver a gene that improves heart function and boosts mitochondrial health in mice, leading to better cardiac performance.
  • The study also reveals that the gene PERM1 interacts with troponin C, a key protein for muscle contraction, and enhances its expression, suggesting a new therapeutic strategy for systolic heart failure.
View Article and Find Full Text PDF